Page 13 - U.S. Growth Healthcare Stocks

UPDATED Mar 15, 2024

Discover U.S. Healthcare Growth Stocks that are on the NYSE and NASDAQ. Sorted by forecasted growth, these Healthcare Stocks have higher than expected earnings or sales growth compared to other companies.

351 companies
CompanyLast Price7D Return1Y ReturnMarket CapAnalysts TargetValuationGrowthDiv Yield

NRC

National Research
US$39.70-1.9%-6.7%US$946.1mn/aPE30.6xn/a1.2%

UTMD

Utah Medical Products
US$69.27-0.06%-25.1%US$252.7mn/aPE15.1xn/a1.7%

WORX

SCWorx
US$1.726.8%-68.1%US$2.2mn/aPB0.3xn/an/a

BTCY

Biotricity
US$1.28-11.1%-66.1%US$11.5mn/aPS1xS17.3%n/a

EAR

Eargo
US$2.57-2.7%-64.3%US$53.4mn/aPS1.3xn/an/a

ELMD

Electromed
US$17.521.9%73.3%US$142.2mUS$26.00PE38.3xn/an/a

GEG

Great Elm Group
US$2.129.7%-6.2%US$60.1mn/aPS5.8xn/an/a

AKLI

Akili
US$0.26-25.0%-80.1%US$20.3mn/aPS11.9xS38.0%n/a

MDGS

Medigus
US$2.70-6.9%-35.9%US$5.1mn/aPB0.2xn/an/a

LUCY

Innovative Eyewear
US$0.34-9.8%-77.9%US$4.3mn/aPS7.3xn/an/a

PMD

Psychemedics
US$2.96-1.3%-46.8%US$16.9mn/aPB2.3xn/a0%

AONC

American Oncology Network
US$5.70-0.002%-44.4%US$210.0mn/aPE-36.2xn/an/a

SNDA

Sonida Senior Living
US$26.1639.2%148.9%US$248.5mn/aPS1.3xn/an/a

TLIS

Talis Biomedical
US$9.1012.8%11.5%US$16.0mn/aPS7.5xn/an/a

FONR

FONAR
US$21.89-3.4%36.0%US$143.6mn/aPE11.4xn/an/a

BIMI

BIMI Holdings
US$2.81-26.1%323.2%US$35.8mn/aPS3.1xn/an/a

AIH

Aesthetic Medical International Holdings Group
US$0.33-31.1%-70.5%US$16.4mn/aPB2.5xn/an/a

EUDA

EUDA Health Holdings
US$1.4822.3%-31.2%US$31.4mn/aPS4.8xn/an/a

MHUA

Meihua International Medical Technologies
US$0.809.6%-94.6%US$18.8mn/aPE2.9xn/an/a

NHC

National HealthCare
US$92.26-0.3%66.4%US$1.4bn/aPE21.2xn/a2.6%

MBOT

Microbot Medical
US$1.11-13.3%-54.9%US$15.1mUS$8.00PB2xn/an/a

HCTI

Healthcare Triangle
US$1.902.7%-44.1%US$8.0mn/aPB1.3xn/an/a

ETAO

ETAO International
US$0.13-24.2%-92.3%US$13.5mn/aPB8.8xn/an/a

ZOM

Zomedica
US$0.13-6.0%-30.3%US$127.7mn/aPS5.2xn/an/a
Page 13 of 15
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.